The firms aim to use Azure AI to process clinical notes, lab tests, genomic data, images, and other often inaccessible data to identify personalized treatments.
SAN ANTONIO, October 18, 2024--bioAffinity Technologies announces pricing of $2.66 million registered direct offering and ...
Researchers have mapped the genetic landscape of cancer drug resistance, uncovering that DNA changes can be grouped into four ...
London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. | ...
All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for drug development and identify potential effective ...
Cambridge scientists and collaborators have mapped drug resistance across different cancers, highlighted DNA changes that may ...
A ChatGPT-like model can diagnose cancer, assist in selecting treatment options, and predict survival outcomes across various ...
All women should start mammograms at age 40 to screen for breast cancer, regardless of family history. Sponsored by Virginia Mason Franciscan Health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback